BioLargo, Inc.
BLGO
$0.219
-$0.0027-1.22%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.05M | 16.29M | 17.78M | 18.50M | 16.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.05M | 16.29M | 17.78M | 18.50M | 16.82M |
| Cost of Revenue | 7.67M | 9.19M | 9.93M | 10.30M | 8.91M |
| Gross Profit | 6.38M | 7.10M | 7.86M | 8.19M | 7.91M |
| SG&A Expenses | 9.92M | 9.64M | 9.30M | 8.99M | 9.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -1.00K | -42.00K |
| Total Operating Expenses | 20.40M | 21.72M | 22.11M | 21.82M | 20.58M |
| Operating Income | -6.34M | -5.43M | -4.33M | -3.33M | -3.76M |
| Income Before Tax | -6.60M | -5.49M | -4.35M | -3.64M | -4.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.60 | -5.49 | -4.35 | -3.64 | -4.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.70M | 2.35M | 1.95M | 1.52M | 1.30M |
| Net Income | -3.90M | -3.15M | -2.40M | -2.12M | -2.78M |
| EBIT | -6.34M | -5.43M | -4.33M | -3.33M | -3.76M |
| EBITDA | -6.18M | -5.23M | -4.18M | -3.20M | -3.63M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.21B | 1.20B | 1.19B | 1.18B | 1.17B |
| Average Diluted Shares Outstanding | 1.21B | 1.20B | 1.19B | 1.18B | 1.17B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |